ADAR and neoplasm: ADAR1 augments oncogenic MSI2 effects by editing miR-3144-3p and that the resultant ED_miR-3144-3p(3_A < G) simultaneously suppresses tumor suppressor SLC38A4 expression, contributing to hepatocellular carcinogenesis